| Primary Device ID | 08056771103572 |
| NIH Device Record Key | 0ddb3a15-5d67-47b6-a8d7-7cc22ffbdb63 |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | LIAISON® QuantiFERON® Software |
| Version Model Number | Q0001 |
| Company DUNS | 630822989 |
| Company Name | DIASORIN SPA |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | false |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | true |
| Device Combination Product | false |
| Single Use | false |
| Lot Batch | false |
| Serial Number | true |
| Manufacturing Date | false |
| Expiration Date | false |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 08056771103572 [Primary] |
| NCD | Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis |
| Steralize Prior To Use | false |
| Device Is Sterile | false |
| Public Version Status | New |
| Device Record Status | Published |
| Public Version Number | 1 |
| Public Version Date | 2019-12-17 |
| Device Publish Date | 2019-12-09 |
| 08056771100199 - LIAISON® anti-HAV | 2026-01-19 |
| 08056771100205 - LIAISON® Control anti-HAV | 2026-01-19 |
| 08056771100571 - LIAISON® Rubella IgG | 2026-01-19 |
| 08056771100588 - LIAISON® Rubella IgG TRI-Controls | 2026-01-19 |
| 08056771100618 - LIAISON® Treponema Assay | 2026-01-19 |
| 08056771101943 - LIAISON® CMV IgM | 2026-01-15 |
| 08056771104029 - LIAISON® Biotrin Parvovirus B19 IgG Plus | 2024-04-16 Italy manufactured kit. |
| 08056771104036 - LIAISON® Biotrin Control Parvovirus B19 IgG Plus | 2024-04-16 Italy manufactured kit. |